Week12, 2024
1. Influenza activity remains elevated but is decreasing nationally, with 10.5% of respiratory specimens testing positive for influenza.
2. Among 403 samples from public health labs, 59.3% were Influenza A and 40.7% Influenza B, with A(H3N2) slightly more common than A(H1N1)pdm09.
3. Cumulative hospitalization rate stands at 72.2 per 100,000, with the highest rate among adults aged 65+ years.
4. Influenza accounted for 0.5% of deaths this week, stable from the previous week, and five new pediatric deaths were reported, bringing the season total to 126.
5. Outpatient respiratory illness visits constituted 3.1% of visits, slightly above baseline but continuing to decline.
6. A novel A(H1N2)v virus infection was identified in a patient with recent swine contact, with no evidence of human-to-human transmission.
7. Influenza A accounts for 70.6% of cumulative clinical lab positives, with Influenza B making up 29.4%.
8. CDC reports widespread co-circulation of influenza, COVID-19, and RSV, complicating trends in ILI and respiratory disease surveillance.
9. Annual vaccination is recommended for all individuals aged six months and older, with vaccination this season still providing benefits.
10. Regions 7, 5, and 1 show the highest positivity rates for influenza, indicating regional variances in viral spread.